Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. NPJ Parkinsons Dis. 2025 Aug 13;11(1):241. doi: 10.1038/s41531-025-01103-y. NPJ Parkinsons Dis. 2025. PMID: 40804248 Free article. No abstract available.
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.
Sehgal P, Naqvi AS, Higgins M, Liu J, Harvey K, Jarroux J, Kim T, Mankaliye B, Mishra P, Watterson G, Fine J, Davis J, Hayer KE, Castro A, Mogbo A, Drummer C 4th, Martinez D, Koptyra MP, Ang Z, Wang K, Farrel A, Quesnel-Vallieres M, Barash Y, Spangler JB, Rokita JL, Resnick AC, Tilgner HU, De Raedt T, Powell DJ Jr, Thomas-Tikhonenko A. Sehgal P, et al. Among authors: martinez d. Cell Rep. 2025 Aug 7;44(8):116099. doi: 10.1016/j.celrep.2025.116099. Online ahead of print. Cell Rep. 2025. PMID: 40782352 Free article.
Colectomy and Neoplasia Outcomes of Patients With Ulcerative Colitis Receiving Golimumab: A Post-Authorisation Safety Study Using the Spanish ENEIDA Registry.
Domènech E, Fortuny J, Martínez D, Tormos A, Huang Z, Hill DD, Weinstein C, Esslinger S, Krumme AA, Otero-Lobato M, Mines D, Gisbert JP; ENEIDA Study Group of GETECCU. Domènech E, et al. Among authors: martinez d. Pharmacoepidemiol Drug Saf. 2025 Aug;34(8):e70176. doi: 10.1002/pds.70176. Pharmacoepidemiol Drug Saf. 2025. PMID: 40721990 Free PMC article.
Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study).
Reguart N, Sampietro-Colom L, Juan-Vidal Ò, Aguiló M, Arriola E, Sánchez J, Fernández-Barceló C, Abbas I, López C, Botella X, Cots F, Teixido C, Martínez D, Palanca S, Borràs E, Masfarré L, Siles Cuesta C, Gas Lopez ME, Planellas L, Lloansí A. Reguart N, et al. Among authors: martinez d. Lung Cancer. 2025 Aug;206:108677. doi: 10.1016/j.lungcan.2025.108677. Epub 2025 Jul 22. Lung Cancer. 2025. PMID: 40712287
2,561 results